Miltefosine and Paromomycin

DRUG2 trials

Sponsors

Drugs for Neglected Diseases, Fundacion Nacional de Dermatologia

Conditions

Cutaneous Leishmaniasis, AmericanVisceral Leishmaniasis

Phase 2

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

CompletedNCT03829917

Fundacion Nacional de DermatologiaCutaneous Leishmaniasis, American

Start: 2019-02-01End: 2020-12-31Updated: 2021-02-02

Phase 3

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

CompletedNCT00696969

Drugs for Neglected DiseasesVisceral Leishmaniasis

Start: 2008-06-30End: 2010-01-31Updated: 2010-02-11

Related Papers

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.

2011-01-20218 citations